Terns Pharmaceuticals Inc
NASDAQ:TERN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
US |
|
E
|
EnChem Co Ltd
KOSDAQ:348370
|
KR |
|
W
|
Welcron Co Ltd
KOSDAQ:065950
|
KR |
|
T
|
Theon International Plc
AEX:THEON
|
CY |
|
Sensei Biotherapeutics Inc
NASDAQ:SNSE
|
US |
|
K
|
Kulthorn Kirby PCL
SET:KKC
|
TH |
Wall Street
Price Targets
TERN Price Targets Summary
Terns Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
TERN
is 51.82 USD
with a low forecast of 17.17 USD and a high forecast of 60.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TERN's stock price target?
Price Target
51.82
USD
According to Wall Street analysts, the average 1-year price target for
TERN
is 51.82 USD
with a low forecast of 17.17 USD and a high forecast of 60.9 USD.